Fulcrum Therapeutics Funding: $55M Raised, Series A (2016)
Fulcrum Therapeutics is based in Cambridge, MA. It has raised $55M in total funding. Latest round: Series A. Backed by Third Rock Ventures, LLC.
Fulcrum Therapeutics funding overview
Fulcrum Therapeutics is based in Cambridge, MA. Fulcrum Therapeutics has raised $55M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2016. The round record for Fulcrum Therapeutics runs through 2016; nothing later has been disclosed. Investors on record include Third Rock Ventures, LLC.
Fulcrum Therapeutics at a glance
Total raised
$55M
Latest round
Series A
Latest round date
July 2016
Headquarters
Cambridge, MA
Notable investors
Third Rock Ventures, LLC
Frequently asked about Fulcrum Therapeutics funding
How much has Fulcrum Therapeutics raised?
Fulcrum Therapeutics has raised $55M in total disclosed funding across the rounds on record.
Who has invested in Fulcrum Therapeutics?
Third Rock Ventures, LLC are named among the investors backing Fulcrum Therapeutics.
What was the latest Fulcrum Therapeutics funding round?
The most recent disclosed round is a Series A, announced in July 2016.
Where is Fulcrum Therapeutics based?
Fulcrum Therapeutics is based in Cambridge, MA.
When did Fulcrum Therapeutics last raise?
The last disclosed Fulcrum Therapeutics round closed in July 2016 at Series A.
Fulcrum Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.
